chloramphenicol
Commercial- Indications
- Bacterial infections
Company intelligence / Profile preview
GALVmed has enabled the registration and commercialization of multiple new or improved animal health products—including vaccines, pharmaceuticals, and diagnostics—targeted at improving livestock productivity for smallholder farmers. The organization manages large-scale initiatives such as PREVENT and VITAL that have delivered effective veterinary solutions across Africa and Asia. It also manages global innovation competitions like the Brucellosis Vaccine Prize to catalyze new vaccine development.
1 more asset in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Glavmed.